Edward Poon, MD
Interventional Pain Medicine · Albuquerque, NMNPI 1770587115
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by Medtronic at 35.8% of the total.
Across 22 payments — averaging $101.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$802
- Si-bone, Inc.$597
- Inari Medical, Inc.$422
- Angiodynamics, Inc.$133
- Nevro Corp.$127
- Relievant Medsystems, Inc.$111
- plus $49 from 3 others
What the payments were for
- Travel & lodging$1,12850%
- Food & beverage$1,11250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 7 | $802 |
| Si-bone, Inc. | 6 | $597 |
| Inari Medical, Inc. | 3 | $422 |
| Angiodynamics, Inc. | 1 | $133 |
| Nevro Corp. | 1 | $127 |
| Relievant Medsystems, Inc. | 1 | $111 |
| Boston Scientific | 1 | $21 |
| Nalu Medical, Inc. | 1 | $15 |
| Medline Industries LP | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HawkOne$598
- IFUSE IMPLANT SYSTEM$450
- FLOWTRIEVER CATHETER, S$377
- CT THROMBECTOMY SYSTEM KIT$377
- Intracept$222
- AngioVac$133
- Omnia$127
How this compares
Too few interventional pain medicine providers in New Mexicoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 12 | $6,722 |
| Oxycodone Hcl | 93 | $1,946 |
| Tizanidine Hcl | 52 | $1,535 |
| Gabapentin | 68 | $1,003 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $590 |
| Morphine Sulfate ErMorphine Sulfate | 25 | $564 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $449 |
| Baclofen | 32 | $372 |
| Pregabalin | 31 | $315 |
| Diclofenac Sodium | 14 | $246 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 14 | $171 |
| Ibuprofen | 14 | $87 |
| Diazepam | 11 | $34 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Albuquerque
- Reuel MeasomAlbuquerque$49K
- Diego GonzalezAlbuquerque$35K
- Athanasios ManoleAlbuquerque$9K
- Craig NairnAlbuquerque$4K
- Kyle SchoenbergerAlbuquerque$2K
- Michael MalizzoAlbuquerque$462
- Cesar VelardeLas Cruces$3K
- Jose RamirezLas Cruces$714
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.